Skip to main content

Advertisement

Log in

Factors Associated with HPV Vaccine Awareness in a Population-Based Sample of Hispanic Women in Puerto Rico

  • Published:
Journal of Racial and Ethnic Health Disparities Aims and scope Submit manuscript

Abstract

Objectives

The objective of this study was to investigate the factors associated with HPV awareness among women aged 16 to 64 years, among underserved minority Hispanic women living in Puerto Rico.

Methods

A population-based, cross-sectional sample of 566 women, ages 16 to 64 years, living in the San Juan metropolitan area were surveyed regarding sexual behavior, HPV knowledge, and HPV vaccine uptake. Data was analyzed using descriptive statistics and multivariate logistic regression.

Results

Overall, 64.8 % of the women in the sample had heard about the HPV vaccine. Among those in the recommended catch-up vaccination age range (16–26 years, n = 86), 4.7 % had received at least one dose of the HPV vaccine. Of those aware of the availability of the HPV vaccine, most had learned about it through the media, whereas, only 39.6 % had learned about it from a physician. Multivariate logistic regression analysis showed that HPV awareness (OR 8.6; 95 % CI 5.0–14.8) and having had an abnormal Pap smear (OR 2.0; 95 % CI 1.2–3.4) were associated with HPV vaccine awareness (p < 0.05).

Conclusion

HPV vaccine awareness among Hispanic women in the San Juan metropolitan area of Puerto Rico continues to be low. Strong recommendations from physicians and participation in HPV vaccine educational efforts are essential if the rate of HPV vaccination is to increase in the targeted population. Compared to the USA, and to their US Hispanic counterparts, a health disparity with regard to HPV vaccine awareness and coverage is evident in Puerto Rico; targeted action to deal with this disparity is urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813–9.

    Article  CAS  PubMed  Google Scholar 

  2. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007;107(2 Suppl 1):S2-5. Review.

    PubMed  Google Scholar 

  3. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–44.

    Article  CAS  PubMed  Google Scholar 

  4. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, et al. Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105(3):175–201. doi:10.1093/jnci/djs491.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Centers for Disease Control and Prevention. HPV Vaccine Information Statement. http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv-gardasil.pdf. Accessed 20 March 2014.

  6. Markowitz L, Dunne E, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization practices (ACIP). CDC Morb Mortal Wkly Rep (MMWR). 2014;63(RR-5):1–30.

    Google Scholar 

  7. Adams M, Jasani B, Fiander A. Human papillomavirus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine. 2007;25(16):3007–13.

    Article  CAS  PubMed  Google Scholar 

  8. FDA News Release. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. December 10, 2014. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426485.htm. Accessed 15 March 2015.

  9. Markowitz L. “Overview of issues and considerations: HPV vaccination recommendation options.” Advisory Committee on Immunization Practices meeting Oct 30, 2014.http://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2014-10/HPV-05-Markowitz.pdf. Accessed 15 March 2015.

  10. The HPV Vaccine: Access and Use in the U.S. Kaiser Family Foundation. http://kff.org/womens-health-policy/fact-sheet/the-hpv-vaccine-access-and-use-in/. Accessed 15 March 2015.

  11. Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer. A Report to the President of the United States from the President’s Cancer Panel. Bethesda, MD: National Cancer Institute; 2014. http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/PDF/PCP_Annual_Report_2012-2013.pdf, Accessed 15 March 2015.

  12. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER.Quadrivalent human papillomavirus vaccine. Cent Dis Control Prev Morb Mortal Wkly Rep (MMWR) 2007: 56(RR02), 1–24. www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm. Date Last Accessed 15 March 2015.

  13. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report (MMWR). National, state, and local area vaccination coverage among adolescents aged 13–17 years—United States, 2009. August 20, 2010:59(32):1019–1023. www.cdc.gov/mmwr/preview/mmwrhtml/mm5932a3.htm?s_cid=mm5923a3_e%0d%0a

  14. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report (MMWR). (2011). National and state vaccination coverage among adolescents aged 13–17 years—United States, 2010. August 26, 2011 : 60(33);1117-1123http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6033a1.htm Date Last Accessed 15 March 2015.

  15. Williams WW, Lu P, Saraiya M, Yankey D, Dorrel C, Rodriguez JL, et al. Factors associated with human papillomavirus vaccination among young women in the United States. Vaccine. 2013;31:2937–46.

    Article  PubMed  Google Scholar 

  16. Elam-Evans LD, Yankey D, Jevarajah J, Singleton JA, Curtis CR, MacNeil J, Hariri S. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2013. CDC MMRW. July 25, 2014: 63(29);625–33. http://www.cdc.gov/mmwr/pdf/wk/mm6329.pdf. Accessed 15 March 2015.

  17. Kester LM, Gregory D, Zimet J, Fortenberry D, Kahn JA, Shew ML. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J. 2013;17(5):879–85. doi:10.1007/s10995-012-1066-z.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Berenson AB, Male E, Lee TG, Barrett A, Sarpong KO, Rupp RE, et al. Assessing the need for and acceptability of a free-of-charge postpartum HPV vaccination program. Am J Obstet Gynecol. 2014;210(3):213.e1–7. doi:10.1016/j.ajog.2013.11.036.

    Article  Google Scholar 

  19. McDougall JA, Madeleine MM, Daling JR, Li CI. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992–2003. Cancer Causes Control. 2007;18(10):1175–86.

    Article  PubMed  Google Scholar 

  20. Gelman A, Nikolajski C, Schwarz EB, Borrero S. Racial disparities in awareness of the human papillomavirus. J Womens Health. 2011;20(8):1165–73. doi:10.1089/jwh.2010.2617.

    Article  Google Scholar 

  21. Wisk LE, Allchin A, Witt WP. Disparities in human papillomavirus vaccine awareness among U.S. parents of preadolescents and adolescents. Sex Transm Dis. 2014;41(2):117–22. doi:10.1097/OLQ.0000000000000086.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Blake KD, Ottenbacher AJ, Finney Rutten LJ, Grady MA, Kobrin SC, Jacobson RM, et al. Predictors of human papillomavirus awareness and knowledge in 2013: gaps and opportunities for targeted communication strategies. Am J Prev Med. 2015;48(4):402–10. doi:10.1016/j.amepre.2014.10.024.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ward E, Jemal A, Cokkinides V, Singh CK, Cardinez C, Ghafoor A, et al. Cancer Disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93.

    Article  PubMed  Google Scholar 

  24. Tiro JA, Meissner HI, Kobrin S, Chollete V. What do women in the U.S. know about human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(2):288–94.

    Article  PubMed  Google Scholar 

  25. Weinick RM, Jacobs EA, Stone LC, Ortega AN, Burstin H, Hispanic Healthcare Disparities. Challenging the myth of a monolithic Hispanic population. Med Care. 2004;42(4):313–20.

    Article  PubMed  Google Scholar 

  26. Ennis SR, Ríos-Vargas M, Albert NG. The Hispanic Population: 2010. 2010 Census Briefs. U.S. Department of Commerce Economics and Statistics Administration, U.S. Census Bureau. C2010BR-04. http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf. Accessed 19 March 2015.

  27. Pew Research Center 2014 Cohn D, Patten E, Hugo-Lopez M. Puerto Rican Population Declines on Island, Grows on U.S. Mainland. Pew Research Center. August 11, 2014. http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf. Accessed 19 March 2015.

  28. Ho GYF, Quian H, Kim MY, Melnik TA, Tucker KL, Jimenez-Velazquez IZ, et al. Health disparities between island and mainland Puerto Ricans. Rev Panam Salud Publica. 2006;19(5):331–9.

    Article  PubMed  Google Scholar 

  29. Colón-López V, Ortiz AP, Palefsky J. Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. PR Health Sci J. 2010;29(3):232–40.

    Google Scholar 

  30. Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin. 2012;62(5):283–98. doi:10.3322/caac.21153.

    Article  PubMed  Google Scholar 

  31. Tortolero-Luna G, Zavala-Zegarra D, Pérez-Ríos N, Torres-Cintrón CR, Ortiz-Ortiz KJ, Traverso-Ortiz M, Román-Ruiz Y, Veguilla-Rosario I, Vázquez-Cubano N, Merced-Vélez MF, Ojeda-Reyes G, Hayes-Vélez FJ, Ramos-Cordero M, López-Rodríguez A, Pérez-Rosa N. Cancer in Puerto Rico, 2006–2010: Incidence and Mortality. Puerto Rico Central Cancer Registry. San Juan, PR. 2013. http://biblioteca.uprh.edu/doc/Cancer-in-Puerto-Rico-2006-2010.pdf. Last Accessed 15 March 2015.

  32. Ortiz AP, Soto-Salgado M, Calo WA, Tortolero-Luna G, Pérez CM, Romero CJ, Pérez J, Figueroa-Vallés N, Suárez E. Incidence and mortality rates of selected infection-related cancers in Puerto Rico and in the United States. Infect Agent Cancer. 2010;May 14;5:10.

  33. Ortiz-Ortiz KJ, Ortiz-Ortiz KJ, Pérez-Irizarry J, Marín-Centeno H, Ortiz AP, Torres-Berrios N, et al. Productivity loss in Puerto Rico’s labor market due to cancer mortality. P R Health Sci J. 2010;3:241–9.

    Google Scholar 

  34. Traverso-Ortiz M. The rise of cervical cancer in Puerto Rico: Are policies effective? Presentation. North American Association of Central Cancan Registries Annual Conference. June 26, 2014.

  35. Fernández ME, Le YL, Fernández-Espada N, Calo WA, Savas LS, Vélez C, et al. Knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination among Puerto Rican mothers and daughters, 2010: a qualitative study. Prev Chronic Dis. 2014;11:140171. doi:10.5888/pcd11.140171.

    Article  Google Scholar 

  36. Ortiz AP, Marrero E, Muñoz C, Pérez C.M, Tortolero-Luna G, Romaguera J, Suárez E. Methods in HPV surveillance: Experiences from a population-based study of HPV infection among women in the San Juan Metropolitan Area of Puerto Rico. P R Health Sci J. 2015:(In press).

  37. Moscoso-Alvarez M, Rodriguez-Figueroa L, Ortiz AP, Reyes-Pulliza JC, Colon H. HPV vaccine knowledge and practice among adolescents in Puerto Rico. Oral Presentation. Am Publ Health Assoc Annu Meet. 2014.

  38. Morales-Campos DY, Markham CM, Peskin MF, Fernandez ME. Hispanic mothers' and high school girls' perceptions of cervical cancer, human papilloma virus, and the human papilloma virus vaccine. J Adolesc Health. 2013;52(5 Suppl):S69–75. doi:10.1016/j.jadohealth.2012.09.020.

    Article  PubMed  Google Scholar 

  39. Reimer RA, Schommer JA, Houlihan AE, Gerrard M. Ethnic and gender differences in HPV knowledge, awareness, and vaccine acceptability among White and Hispanic men and women. J Community Health. 2014;39(2):274–84. doi:10.1007/s10900-013-9773-y.

    Article  PubMed  Google Scholar 

  40. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82. doi:10.1001/jamapediatrics.2013.2752.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Fu LY, Bonhomme LA, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine. 2014. doi:10.1016/j.vaccine.2014.01.091.

    Google Scholar 

  42. Hendry M, Lewis R, Clements A, Damery S, Wilkinson C. "HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination. Vaccine. 2013;31(45):5152–67. doi:10.1016/j.vaccine.2013.08.091.

    Article  PubMed  Google Scholar 

  43. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect. 2003;79(4):320–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Gerend MA, Zapata C, Reyes E. Predictors of human papillomavirus vaccination among daughters of low-income Latina mothers: the role of acculturation. J Adolesc Health. 2013;53(5):623–9. doi:10.1016/j.jadohealth.2013.06.006.

    Article  PubMed  Google Scholar 

  45. Wong, Ker Y, and Young K Do. Are there socioeconomic disparities in women having discussions on human papillomavirus vaccine with health care providers? BMC Women's Health. 2012:12.33. doi:10.1186/1472-6874-12-33.

  46. Almeida CM, Tiro JA, Rodriguez MA, Diamant AL. Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California. Vaccine. 2012;30(19):3003–8. doi:10.1016/j.vaccine.2012.01.079.

    Article  PubMed  Google Scholar 

  47. Fernández ME, Le YL, Fernández-Espada N, Calo WA, Savas LS, Vélez C, et al. Knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination among Puerto Rican mothers and daughters, 2010: a qualitative study. Prev Chronic Dis. 2014;11:140171.

    Article  Google Scholar 

Download references

Acknowledgments

This project was funded by the National Institute of Allergy and Infectious Diseases (Grant 1 SC2 AI090922-01) and by the National Institute on Minority Health and Health Disparities (under award number 2U54MD007587) of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Informed Consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Institutional and National) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all the patients who took part in the study.

Conflict of Interests

Romaguera J., Caballero-Varona D., Tortolero-Luna G., Marrero E., Suárez E., Pérez CM, Muñoz C., Ortiz AP, and Palefsky J. all declare that there are no conflicts of interest regarding the research reported in or publication of this paper.

Animal Studies

No animal studies were carried out by the authors for this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Romaguera.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Romaguera, J., Caballero-Varona, D., Tortolero-Luna, G. et al. Factors Associated with HPV Vaccine Awareness in a Population-Based Sample of Hispanic Women in Puerto Rico. J. Racial and Ethnic Health Disparities 3, 281–290 (2016). https://doi.org/10.1007/s40615-015-0144-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40615-015-0144-5

Keywords

Navigation